semaglutide 2.0 mg approval U.S. FDA | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight Ozempic 2 mg/1.5 mL (1.34

It's important to note that Wegovy should be discontinued immediately if pregnancy occurs, as semaglutide is contraindicated in pregnancy and breastfeeding

The peptide bonds break down in ways that cannot be reversed by re-refrigerating the penputting a warm pen back in the fridge does not restore its potency

While there is not a lot of research comparing the two side by side, some In a 2021 study, the researchers noted that those who injected semaglutide showed more of a reduction in body weight compared to other people who took other approved weight loss medications, such as phentermine

[1] Furthermore, the dose escalation schedule for Wegovystarting at 0.25 mg weekly and gradually increasing to the maintenance dose of 2.4 mgis designed to improve tolerability, but each dose increase can temporarily intensify side effects, as noted in the SmPC

these are not specific to vaginal endpoints but support monitoring hydration status